BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock
Shares outstanding
210,587,372
Total 13F shares
83,706,610
Share change
+14,652,773
Total reported value
$438,584,580
Put/Call ratio
387%
Price per share
$5.24
Number of holders
118
Value change
+$76,310,817
Number of buys
64
Number of sells
43

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAKER BROS. ADVISORS LP
13F
Company
5.6%
11,716,784
$65,145,000 30 Jun 2017
13F
BlackRock Finance, Inc.
13F
Company
3%
6,258,377
$34,796,000 30 Jun 2017
13F
VANGUARD GROUP INC
13F
Company
2.9%
6,007,815
$33,404,000 30 Jun 2017
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
2.5%
5,162,242
$28,702,000 30 Jun 2017
13F
STATE STREET CORP
13F
Company
1.9%
3,909,013
$21,736,000 30 Jun 2017
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.7%
3,499,202
$19,456,000 30 Jun 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.6%
3,405,864
$18,937,000 30 Jun 2017
13F
RTW INVESTMENTS, LP
13F
Company
1.6%
3,333,958
$18,537,000 30 Jun 2017
13F
FMR LLC
13F
Company
1.5%
3,124,676
$17,373,000 30 Jun 2017
13F
VHCP Management II, LLC
13F
Company
1.2%
2,475,167
$13,762,000 30 Jun 2017
13F
D. E. Shaw & Co., Inc.
13F
Company
0.99%
2,088,007
$11,609,000 30 Jun 2017
13F
JENNISON ASSOCIATES LLC
13F
Company
0.99%
2,080,818
$11,569,000 30 Jun 2017
13F
Avoro Capital Advisors LLC
13F
Company
0.93%
1,953,525
$10,862,000 30 Jun 2017
13F
NORTHERN TRUST CORP
13F
Company
0.48%
1,006,840
$5,599,000 30 Jun 2017
13F
Invesco Ltd.
13F
Company
0.45%
956,224
$5,317,000 30 Jun 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.44%
924,757
$5,141,000 30 Jun 2017
13F
Artal Group S.A.
13F
Company
0.4%
850,000
$4,726,000 30 Jun 2017
13F
Ghost Tree Capital, LLC
13F
Company
0.32%
675,000
$3,753,000 30 Jun 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.31%
654,584
$3,639,000 30 Jun 2017
13F
DAFNA Capital Management LLC
13F
Company
0.28%
591,128
$3,287,000 30 Jun 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.25%
519,303
$2,886,000 30 Jun 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.22%
468,882
$2,607,000 30 Jun 2017
13F
University Of Notre Dame du Lac
13F
Individual
0.2%
422,767
$2,351,000 30 Jun 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.19%
404,503
$2,249,000 30 Jun 2017
13F
Bank of New York Mellon Corp
13F
Company
0.18%
369,520
$2,055,000 30 Jun 2017
13F
PAULSON & CO. INC.
13F
Company
0.17%
349,500
$1,943,000 30 Jun 2017
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.16%
341,013
$1,896,000 30 Jun 2017
13F
MORGAN STANLEY
13F
Company
0.15%
317,899
$1,768,000 30 Jun 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.15%
307,811
$1,712,000 30 Jun 2017
13F
A.R.T. Advisors, LLC
13F
Company
0.15%
307,616
$1,710,000 30 Jun 2017
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.14%
290,000
$1,612,000 30 Jun 2017
13F
EMORY UNIVERSITY
13F
Company
0.14%
287,550
$1,599,000 30 Jun 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.12%
244,613
$1,360,000 30 Jun 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.09%
196,385
$1,092,000 30 Jun 2017
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.08%
168,685
$938,000 30 Jun 2017
13F
BARCLAYS PLC
13F
Company
0.08%
162,656
$904,000 30 Jun 2017
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
155,858
$866,000 30 Jun 2017
13F
ROYCE & ASSOCIATES LP
13F
Company
0.07%
144,000
$801,000 30 Jun 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.07%
141,883
$789,000 30 Jun 2017
13F
PDT Partners, LLC
13F
Company
0.06%
129,200
$718,000 30 Jun 2017
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.06%
118,674
$660,000 30 Jun 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.06%
118,300
$658,000 30 Jun 2017
13F
Allianz Asset Management GmbH
13F
Company
0.06%
117,637
$654,000 30 Jun 2017
13F
Swiss National Bank
13F
Company
0.05%
114,300
$636,000 30 Jun 2017
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.05%
107,620
$598,000 30 Jun 2017
13F
CREDIT SUISSE AG/
13F
Company
0.05%
106,286
$590,000 30 Jun 2017
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.05%
100,000
$556,000 30 Jun 2017
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
94,303
$524,000 30 Jun 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.04%
83,800
$466,000 30 Jun 2017
13F
ALPS ADVISORS INC
13F
Company
0.03%
72,591
$404,000 30 Jun 2017
13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q3 2017

As of 30 Sep 2017, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 83,706,610 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, DEERFIELD MANAGEMENT CO, JANUS HENDERSON GROUP PLC, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LP, VHCP Management II, LLC, and FMR LLC. This page lists 118 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 holders
112
Q3 2017 holders
118
Holder diff
6
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 Value $ Q3 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.